By Professor David Simon Ziegler

Conference Abstracts

Tsoli M; Yeung N; Valvi S; Joshi S; Franshaw L; Shen H; Liu J; Ziegler D, 2017, 'COMBINATION OF SYNTHETIC RETINOID FENRETINIDE WITH RECEPTOR TYROSINE KINASE INHIBITOR PONATINIB AS A POTENTIAL NEW APPROACH AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, NY, New York, Vol. 19, pp. 5 - 6, presented at 4th Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research, NY, New York, 15 June 2017 - 16 June 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402766800022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lau L; Byrne J; Ekert PG; Failes T; Fellowes A; Fletcher J; Gifford A; Haber M; Kumar A; Lock R; Marshall G; McCowage GB; Mould E; Norris M; Trahair T; Tsoli M; Tyrrell V; Wadham C; Xie J; Ziegler DS, 2017, 'Pilot study of a comprehensive precision medicine platform for children with high-risk cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 35, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2017 - 06 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.10539

Shen H; Chang C; Joshi S; Liu J; Tsoli M; Hau E; Ziegler D, 2017, 'DIPG-02. RADIOSENSITIVITY OF DIPG CELLS IS ENHANCED BY TARGETING GLUCOSE METABOLISM IN VITRO AND IN VIVO', in Neuro-Oncology, Oxford University Press (OUP), Vol. 19, pp. iv5 - iv5, http://dx.doi.org/10.1093/neuonc/nox083.017

Tsoli M; Lapin D; Franshaw L; Shen H; Liu J; Ziegler D, 2017, 'DIPG-04. COMBINED TARGETING OF CALCIUM SIGNALLING AND RTK/PI3K PATHWAY IS A NOVEL THERAPEUTIC APPROACH AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA', in Neuro-Oncology, Oxford University Press (OUP), Vol. 19, pp. iv5 - iv5, http://dx.doi.org/10.1093/neuonc/nox083.019

Tsoli M; Yeung N; Valvi S; Joshi S; Franshaw L; Shen H; Liu J; Ziegler D, 2017, 'DIPG-05. COMBINATION OF SYNTHETIC RETINOID FENRETINIDE WITH RECEPTOR TYROSINE KINASE INHIBITOR PONATINIB AS A POTENTIAL NEW APPROACH AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA', in Neuro-Oncology, Oxford University Press (OUP), Vol. 19, pp. iv5 - iv6, http://dx.doi.org/10.1093/neuonc/nox083.020

Franshaw L; Chang C; Joshi S; Ehteda A; Tsoli M; Ziegler D, 2017, 'DIPG-07. INDUCING DNA LETHALITY THROUGH POLO-LIKE KINASE 1 INHIBITION: A NOVEL THERAPEUTIC APPROACH IN DIPG', in Neuro-Oncology, Oxford University Press (OUP), Vol. 19, pp. iv6 - iv6, http://dx.doi.org/10.1093/neuonc/nox083.022

Ehteda A; Kankean A; Chitranjan A; Tsoli M; Liu J; Shen H; Franshaw L; Joshi S; Chang C; Ager E; Ziegler DS, 2017, 'DIPG-09. TRX-E-009-1 IS A NOVEL AND A POTENT THERAPEUTIC AGENT FOR DIFFUSE INTRINSIC PONTINE GLIOMAS', in Neuro-Oncology, Oxford University Press (OUP), Vol. 19, pp. iv6 - iv6, http://dx.doi.org/10.1093/neuonc/nox083.024

Franshaw L; Tsoli M; Byrne J; Sivarajasingam S; Norris M; Marshall G; Ziegler D, 2017, 'TRTH-05. PREDICTORS OF SUCCESS OF PHASE 2 PAEDIATRIC ONCOLOGY CLINICAL TRIALS', in Neuro-Oncology, Oxford University Press (OUP), Vol. 19, pp. iv52 - iv52, http://dx.doi.org/10.1093/neuonc/nox083.217

Fardell J; Donovan L; Wakefield C; Russell V; Mitchell R; O'Brien T; Ziegler D; Glenn M; Cohn R, 2016, 'Outcomes of Bereaved Parents Whose Child Did or Did not Participate in An Early Phase Clinical Trial', in PEDIATRIC BLOOD & CANCER, WILEY-BLACKWELL, Vol. 63, pp. S62 - S62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384818800579&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Robertson E; Fardell J; O'Brien T; Cohn R; Mitchell R; Drew D; Ziegler D; Marshall G; Wakefield C, 2016, 'Treatment Decision Making for Young People with Cancer and Their Parents', in PEDIATRIC BLOOD & CANCER, WILEY-BLACKWELL, Vol. 63, pp. S232 - S232, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384818801393&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shen H; Tsoli M; Chang C; Chitranjan A; Liu J; Hau E; Kankean A; Ehteda A; Franshaw L; Valvi S; Ziegler D, 2016, 'HG-04DICHLOROACETATE AND METFORMIN COMBINE TO MODULATE GLUCOSE METABOLISM AND POTENTLY SENSITISE DIPG CELLS TO RADIATION THERAPY', in Neuro-Oncology, Oxford University Press (OUP), Vol. 18, pp. iii48.3 - iii48, http://dx.doi.org/10.1093/neuonc/now073.03

Tsoli M; Chang C; Shen H; Liu J; Chintranjan A; Franshaw L; Dilda P; Carcaboso AM; Hogg P; Ziegler D, 2016, 'HG-19COMBINED TARGETING OF MITOCHONDRIAL FUNCTION AND mTOR IS A POTENT NOVEL THERAPEUTIC APPROACH FOR DIFFUSE INTRINSIC PONTINE GLIOMA', in Neuro-Oncology, Oxford University Press (OUP), Vol. 18, pp. iii51.3 - iii51, http://dx.doi.org/10.1093/neuonc/now073.16

Ehteda A; Tsoli M; Chitranjan A; Chang C; Simon S; Kankean A; Shen H; Liu J; Haber M; Gudkov A; Ziegler D, 2016, 'HG-20COMBINATION OF EPIGENETIC MODIFIERS CBL0137 AND PANOBINOSTAT IS HIGHLY POTENT IN VITRO AND IN VIVO FOR DIFFUSE INTRINSIC PONTINE GLIOMA', in Neuro-oncology, Vol. 18, pp. iii51 - iii51

Valvi S; Tsoli M; Chitranjan A; Shen H; Chang C; Kankean A; Ehteda A; Franshaw L; Liu J; Ziegler D, 2016, 'HG-25FENRETINIDE TARGETS THE RTK-PI3K PATHWAY IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', in Neuro-Oncology, Oxford University Press (OUP), Vol. 18, pp. iii52.5 - iii53, http://dx.doi.org/10.1093/neuonc/now073.22

Kankean A; Ehteda A; Chitranjan A; Tsoli M; Ager E; Ziegler D, 2015, 'BT-09 * TRILEXIUM INHIBITS THE EXPRESSION OF t-NOX AND IS A NOVEL, POTENTIALLY POTENT THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMAS', in Neuro-Oncology, Oxford University Press (OUP), Vol. 17, pp. iii5 - iii5, http://dx.doi.org/10.1093/neuonc/nov061.19

Kankean A; Tsoli M; Tsang J; Chitranjan A; Maleki S; McDonald K; Ziegler D, 2015, 'HG-16 * THE ANTI-APOPTOTIC PROTEIN ARC IS OVER-EXPRESSED IN MALIGNANT GLIOMA AND CORRELATES WITH PATIENT OUTCOME', in Neuro-Oncology, Oxford University Press (OUP), Vol. 17, pp. iii14 - iii14, http://dx.doi.org/10.1093/neuonc/nov061.53

Haber M; Murray J; Gamble L; Carnegie-Clark A; Webber H; Ruhle M; Henderson MJ; Middlemass S; Carter D; Tsoli M; Ehteda A; Simon S; Oberthuer A; Fischer M; Gurova K; Burkhart C; Purmal A; Lock RB; Ziegler D; Marshall GM; Gudkov AV; Norris MD, 2015, 'The FACT histone chaperone complex is highly expressed in aggressive drug refractory childhood cancers and the anti-FACT compound CBL0137 represents a highly promising therapeutic approach in this setting', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-1611

Mitic G; Tsoli M; Ziegler DS; Kavallaris M, 2013, 'beta III-tubulin in glioblastoma: An emerging multifactorial survival factor role in chemotherapy response and tumor formation.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, Vol. 73, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), DC, Washington, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-3431

Mitic G; Tsoli M; Ziegler DS; Kavallaris M, 2012, 'beta III-TUBULIN AND GLIOBLASTOMA: ROLE IN DRUG RESISTANCE AND TUMOURIGENESIS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 8, pp. 303 - 304, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400264&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Mayoh C; Li W; Toumari M; Bazaz SR; Gerard A-L; Lowe A; Barahona P; Lau LMS; Staunton J; Jacobson E; Nagabushan S; Manoharan N; Mitchell R; Ong F; Wong-Erasmus M; Ekert PG; Tyrrell V; Haber M; Ziegler DS; Cowley MJ; Mateos MK; Salomon R, 2025, Single-cell RNA-sequencing of cerebral spinal fluid identifies circulating tumour cells in children with brain cancer, http://dx.doi.org/10.64898/2025.12.18.694991

Duchatel RJ; Savary C; Germon ZP; Riley M; Ziegler DS; Mueller S; Jackson E; Dun MD, 2025, Beyond Base Camp: Promise and Pitfalls of PI3K/mTOR Inhibition in Pediatric High- Grade Gliomas., http://dx.doi.org/10.21203/rs.3.rs-6508597/v1

Mayoh C; Barahona P; Lin A; Cui L; Ajuyah P; Altekoester A; Lau LMS; Khuong-Quang D-A; Sullivan P; Senapati A; Nagabushan S; Sullivan A; Omer N; Moore A; Nicholls W; Endersby R; Gottardo N; McCowage G; Dalla Pozza L; Hansford J; Khaw S-L; Wood P; Trahair T; Marshall G; Ziegler D; Tyrrell V; Haber M; Wong M; Ekert P; Cowley M, 2025, Expanding the utility of transcriptome analysis for mutation detection in high-risk childhood precision oncology, http://dx.doi.org/10.1101/2025.06.25.661445

Ross SE; Holliday H; Wang E; Zeraati M; Tsoli M; Ziegler DS; Dinger ME, 2024, RNA N6-Methyladenosine (m6A) regulates the cell cycle in Diffuse Midline Glioma (DMG) and confers sensitivity to FTO inhibition, http://dx.doi.org/10.21203/rs.3.rs-5390888/v1

Barlow-Stewart K; Barlow-Stewart K; Courtney E; Cowley M; Ebzery C; Bolanos NF; Gifford A; Harden H; Josephi-Taylor S; Kotecha R; Mateos M; Manzur M; Mayoh C; Milnes D; Nielsen J; O'Connor M; Padhye B; Pitman C; Pitman E; Pinese M; Speechly C; Sullivan A; Trahair T; Tucker K; Tyrrell V; Warby M; Wood A; Ziegler D; Johnston C, 2024, Policy and process for returning raw genomic data to parents and young adult participants in a pediatric cancer precision medicine trial., http://dx.doi.org/10.21203/rs.3.rs-4356870/v1

Holliday H; Khan A; Ehteda A; Nguyen H; Ross S; Jayatilleke N; Gopalakrishnan A; Wang E; Colino Sanguino Y; Kavanagh D; Guo X; Liu J; Lawrence D; Sun C; Lehmann R; Ip CK; Lee A; Rangel-Sanchez L; Li W; Salomon R; Firestein R; Weatheritt R; Valdes-Mora F; Dinger M; Phoenix T; Mayoh C; Rayner B; Tsoli M; Ziegler D, 2024, Chromatin remodeling with combined FACT and BET inhibition disrupts oncogenic transcription in Diffuse Midline Glioma, http://dx.doi.org/10.1101/2024.06.06.597703

Fuentes-Bolanos N; Courtney E; Mayoh C; Warby M; Lau L; Wong-Erasmus M; Khuong-Quang D-A; Barahona P; Padhye B; El-Kamand S; Nunag S; Ajuyah P; Sherstyuk A; Altekoester A-K; Sullivan A; Poplawski N; Kiraly-Borri C; O’Sullivan S; Marfan H; Alli R; Curnow L; Bhatia K; Anazodo A; Trahair T; Mateos M; Hansford J; Dholaria H; Josephi-Taylor S; Moore A; Nicholls W; Gottardo N; Downie P; Khaw S-L; Tapp H; McCowage G; Dalla-Pozza L; Alvaro F; Wood P; Tyrrell V; Haber M; Cowley M; Ekert P; Marshall G; Kirk J; Tucker K; Pinese M; Ziegler D, 2024, Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancer, http://dx.doi.org/10.1101/2024.08.08.24311493

Kelada L; Robertson E; McKay S; McGill B; Daly R; Mazariego C; Taylor N; Tyedmers E; Evans HE; Wakefield C; Ziegler D, 2023, Communicating with families of young people with hard-to-treat cancers: Healthcare professionals’ perspectives on challenges, skills, and training, http://dx.doi.org/10.22541/au.168438965.52340962/v1

Duchatel RJ; Jackson ER; Parackal SG; Sun C; Daniel P; Mannan A; Findlay IJ; Staudt D; Germon ZP; Laternser S; Kiltschewskij D; Kearney PS; Fairuz M; Jamaluddin B; Douglas AM; Beitaki T; Persson M; Manning EE; Murray HC; Verrills NM; Skerrett-Byrne DA; Nixon B; Hua S; Fatima V-M; Tsoli M; Ziegler DS; Cairns MJ; Raabe E; Vitanza NA; Koschmann C; Alvaro F; Dayas CV; Tinkle CL; Eisenstat DD; Firestein R; Mueller S; Nazarian J; Cain JE; Dun MD, 2023, PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma, http://dx.doi.org/10.1101/2023.04.17.537256

Fordham A; Brown L; Mayoh C; Salib A; Barger Z; Wong M; Sian TCCLK; Xie J; Gunther K; Trebilcock P; Terry R; Barahona P; Ajuyah P; Sherstyuk A; Avila A; Cadiz R; Perkins C; Gifford A; Mao J; Zhao A; O’Regan L; Gorgels D; Lau LMS; Ziegler D; Haber M; Tyrrell V; Lock R; Cowley M; Nicholls W; Daly R; Ekert P; Fleuren EDG, 2023, Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across pediatric and AYA sarcomas, http://dx.doi.org/10.1101/2023.07.19.548825

Ziegler D; Lau L; Khuong-Quang D-A; Mayoh C; Wong M; Barahona P; Ajuyah P; Senapati A; Nagabushan S; Sherstyuk A; Altekoester A-K; Fuentes-Bolanos N; Yeung V; Sullivan A; Diamond Y; Omer N; Jessop S; Battaglia L; Zhukova N; Cui L; Lin A; Gifford A; Fleuren E; Dalla-Pozza L; Moore A; Khaw S; Eisenstat D; Gottardo N; Wood P; Tapp H; Alvaro F; McCowage G; Nicholls W; Hansford J; Manoharan N; Kotecha R; Mateos M; Lock R; Tyrrell V; Haber M; Trahair T; Cowley M; Ekert P; Marshall G, 2023, Precision-guided treatment improves outcomes for children with high-risk cancers, http://dx.doi.org/10.21203/rs.3.rs-3376668/v1

Lilly JV; Rokita JL; Mason JL; Patton T; Stefankiewiz S; Higgins D; Trooskin G; Larouci CA; Arya K; Appert E; Heath AP; Zhu Y; Brown MA; Zhang B; Farrow BK; Robins S; Morgan AM; Nguyen TQ; Frenkel E; Lehmann K; Drake E; Sullivan C; Plisiewicz A; Coleman N; Patterson L; Koptyra M; Helili Z; Van Kuren N; Young N; Kim MC; Friedman C; Lubneuski A; Blackden C; Williams M; Baubet V; Tauhid L; Galanaugh J; Boucher K; Ijaz H; Cole KA; Choudhari N; Santi M; Moulder RW; Waller J; Rife W; Diskin SJ; Mateos M; Parsons DW; Pollack IF; Goldman S; Leary S; Caporalini C; Buccoliero AM; Scagnet M; Haussler D; Hanson D; Firestein R; Cain J; Phillips JJ; Gupta N; Mueller S; Grant G; Monje-Deisseroth M; Partap S; Greenfield JP; Hashizume R; Smith A; Zhu S; Johnston JM; Fangusaro JR; Miller M; Wood MD; Gardner S; Carter CL; Prolo LM; Pisapia J; Pehlivan K; Franson A; Niazi T; Rubin J; Abdelbaki M; Ziegler DS; Lindsay HB; Stucklin AG; Gerber N; Vaske OM; Quinsey C; Rood BR; Nazarian J; Raabe E; Jackson EM; Stapleton S; Lober RM; Kram DE; Koschmann C; Storm PB; Lulla RR; Prados M; Resnick AC; Waanders AJ, 2022, The Children’s Brain Tumor Network (CBTN) - Accelerating Research in Pediatric Central Nervous System Tumors through Collaboration and Open Science, http://dx.doi.org/10.1101/2022.10.14.511975

Mayoh C; Gifford A; Terry R; Lau LMS; Wong M; Rao P; Shai-Hee T; Saletta F; Khuong-Quang D-A; Qin V; Mateos M; Meyran D; Miller K; Yuksel A; Mould EVA; Bowen-James R; Govender D; Senapati A; Zhukova N; Omer N; Dholaria H; Alvaro F; Tapp H; Diamond Y; Pozza LD; Moore A; Nicholls W; Gottardo N; McCowage G; Hansford J; Khaw S-L; Wood P; Catchpoole D; Cottrell C; Mardis E; Marshall G; Tyrrell V; Haber M; Ziegler D; Vittorio O; Trapani J; Cowley M; Neeson P; Ekert P, 2022, A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer, http://dx.doi.org/10.1101/2022.09.16.508179

Poursani EM; Mercatelli D; Raninga P; Bell JL; Saletta F; Kohane FV; Zheng Y; Rouaen J; Jue TR; Michniewicz FT; Kasiou E; Tsoli M; Cirillo G; Waters S; Shai-Hee T; Valli E; Brettle M; Whan R; Vahadat L; Ziegler D; Lock JG; Giorgi FM; Khanna KK; Vittorio O, 2022, Copper chelation inhibits TGF-βpathways and suppresses epithelial-mesenchymal transition in cancer, http://dx.doi.org/10.1101/2022.10.03.510707

Gargett T; Ebert L; Truong NTH; Kollis P; Sedivakova K; Yu W; Yeo ECF; Wittwer N; Gliddon B; Tea M; Ormsby R; Poonnoose S; Nowicki J; Vittorio O; Ziegler D; Pitson S; Brown M, 2022, GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma, http://dx.doi.org/10.1101/2022.05.01.490250

Tabori U; Morgenstern D; Sudhaman S; Das A; Coblentz A; Chung J; Stone S; Alsafwani N; Cabric V; Nobre L; Bianchi V; Edwards M; Sambira L; Constantini S; Dvir R; Yalon M; Campino G; Caspi S; Larouche V; Reddy A; Osborn M; Mason G; Lindhorst S; Bronsema A; Magimairajan V; Opocher E; De Mola R; Sabel M; Frojd C; Sumerauer D; Samuel D; Cole K; Chiaravalli S; Massimino M; Tomboc P; Ziegler D; George B; Damme AV; Hijaya N; Gass D; McGee R; Mordechai O; Bowers D; Laetsch T; Lossos A; Blumenthal D; Sarosiek T; Yen L; Knipstein J; Bendel A; Hoffman L; Luna-Fineman S; Zimmermann S; Scheers I; Nichols K; Zapotocky M; Hansford J; Maris J; Dirks P; Taylor M; Kulkarni A; Shroff M; Tsang D; Malkin D; Villani A; Aronson M; Durno C; Shlien A; Getz G; Maruvka Y; Ohashi P; Hawkins C; Pugh T; Bouffet E, 2021, Mutation and Microsatellite Burden Predict Response to PD-1 Inhibition in Children with Germline DNA Replication Repair Deficiency, http://dx.doi.org/10.21203/rs.3.rs-155292/v1

Khan S; Solano-Paez P; Suwal T; Lu M; Al-Karmi S; Ho B; AlmeidaGonzalez CV; Stephens D; Dodgshun A; Shago M; Marrano P; Fonseca A; Hoffman LM; Leary S; Lindsay HB; Lassaletta A; Bendel AE; Moertel C; Morales A; Santa-Maria V; Lavarino C; Rivas E; Perreault S; Ellezam B; Jabado N; Oviedo A; Yalon-Oren M; Amariglio L; Toledano H; Loukides J; Van Meter TE; Nakamura H; Wong T-T; Wu K-S; Cheng C-J; Ra Y-S; La Spina M; Massimi L; Buccoliero AM; Reddy A; Li R; Gillespie GY; Adamek D; Fangusaro J; Scharnhorst D; Torkildson J; Johnston D; Michaud J; Lafay-Cousin L; Chan J; Van Landeghem F; Wilson B; Camelo-Piragua S; Kabbara N; Boutarbouch M; Hanson D; Jacobsen C; Wright K; Mulcahy Levy JM; Wang Y; Catchpoole D; Gerber N; Grotzer MA; Shen V; Plant A; Dunham C; da Costa MJG; Ramanujachar R; Raabe E; Rubens J; Philips J; Gupta N; Demir A; Dahl C; Jorgensen M; Hwang EI; Smith A; Tan E; Low S; Lu J-Q; Ho-Keung NG; Kresak JL; Gururangan S; Pomeroy SL; Sirachainan N; Hongeng S; Magimairajan V; Sinha R; Mushtaq N; Antony R; Sato M; Samuel D; Zapotocky M; Afzal S; Amayiri N; Al-Hussaini M; Walter A; Tihan T; Somers GR; Gajjar A; Wood P; Gottardo N; Cain JE; Downie PA; Branson H; Laughlin S; Ertl-Wagner B; Tsang DS; Ramaswamy V; Drake J; Kulkarni AV; Ziegler DS; Nobusawa S; Tabori U; Taylor MD; Ibrahim GM; Rutka JT; Dirks PB; Hazrati L-N; Grundy RG; Fouladi M; Padovani PL; Bourdeaut F; Hansford JR; Bartels U; Dufour C; Hawkins C; Andre N; Bouffet E; Huang A, 2020, Clinical phenotypes and prognostic features of ETMRs (Embryonal Tumor with Multi-layered Rosettes) a new CNS tumor entity: A Rare Brain Tumor Registry study, http://dx.doi.org/10.1101/2020.08.12.20171801

Robertson EG; Wakefield CE; Cohn RJ; O'Brien T; Ziegler DS; Fardell JE, 2017, The Development of Delta: Using Agile to Develop a Decision Aid for Pediatric Oncology Clinical Trial Enrollment (Preprint), http://dx.doi.org/10.2196/preprints.9258

Crothers AL; Haeusler GM; Slavin MA; Babl FE; Mechinaud F; Phillips R; Tapp H; Padhye B; Ziegler DS; Clark J; Walwyn T; Super L; Alvaro F; Thursky K; Lourenco RDA, Examining Health-Related Quality of Life in Pediatric Cancer Patients with Febrile Neutropenia: Factors Predicting for Poor Recovery in Children and the Parents, http://dx.doi.org/10.2139/ssrn.3860325

Other

Barlow-Stewart K; Courtney E; Cowley M; Ebzery C; Fuentes Bolanos N; Gifford AJ; Harden H; Josephi-Taylor S; Kotecha RS; Mateos MK; Manzur M; Mayoh C; Milnes D; Nielsen J; O’Connor M; Padhye B; Pitman C; Pitman E; Pinese M; Speechly C; Sullivan A; Trahair T; Tucker K; Tyrrell V; Warby M; Wood A; Ziegler DS; Johnston C, 2025, Correction to: Returning raw genomic data to research participants in a pediatric cancer precision medicine trial (npj Genomic Medicine, (2025), 10, 1, (12), 10.1038/s41525-025-00470-y), http://dx.doi.org/10.1038/s41525-025-00486-4

Tyrrell V; Mayoh C; Ekert P; Cowley M; Ziegler D; Wong M; Barahona P; Pinese M; Haber M; Salomon R; Courtney E; Lock R; Fuentes-Bolanos N; Marshall G; Warby M; Trahair T; Khuong Quang DA; Wakefield C; Tucker K; Barlow-Stewart K; Padhye B; Lau L, 2025, Zero Childhood Cancer: a national approach to improving outcomes of Australian children with cancer through multiomic precision medicine, Elsevier BV, http://dx.doi.org/10.1016/j.pathol.2024.12.099

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Data from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.c.6960487.v1

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Data from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.c.6960487

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Supplementary Figure 1 from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.24710152.v1

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Supplementary Figure 1 from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.24710152

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Supplementary Figure 2 from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.24710149

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Supplementary Figure 2 from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.24710149.v1

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Supplementary Figure 3 from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.24710146

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Supplementary Figure 3 from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.24710146.v1

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Supplementary Figure 4 from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.24710143

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, Supplementary Figure 4 from Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas, http://dx.doi.org/10.1158/1535-7163.24710143.v1

Back to profile page